Chandelier
Senior Member (Voting Rights)
PDF
Authors: Orlando Alves da Silva, Susan Byrne, Alastair Craw, and Margarida Dolan
ABSTRACT.
Background.
Fatigue with no apparent organic cause is one of the characterising symptoms of ME/CFS, and fatigue is one of many possible symptoms of Proprioception Dysfunction Syndrome (PDS).
The aim of this study was to investigate whether a patient with ME/CFS also had PDS, and to treat the patient following the non-invasive and inexpensive protocol for PDS from [13].
Methods.
A patient with severe ME/CFS was diagnosed with PDS using simple biomechanical tests that investigate body and visual-spatial perception.
The key elements of the treatment involve the use of glasses with ‘Active Prism’ lenses, combined with postural reprogramming.
We subsequently followed four further patients with the characterising symptoms of ME/CFS through diagnosis and treatment for PDS.
Results.
The results show a rapid recovery of the clinical state of the primary patient during the course of the treatment as measured on the Bell Fatigue Scale, allowing him to return quickly to professional life and to re-establish his pre-disease quality of life.
Of the four additional patients, one regained pre-disease levels of function, while the clinical state of the remaining three patients improved measurably.
Conclusions.
Research into the prevalence of PDS among ME/CFS patients should be carried out, and those ME/CFS patients with PDS should undertake the treatment that we describe (begining with postural reprogramming, see Appendix B).
Authors: Orlando Alves da Silva, Susan Byrne, Alastair Craw, and Margarida Dolan
ABSTRACT.
Background.
Fatigue with no apparent organic cause is one of the characterising symptoms of ME/CFS, and fatigue is one of many possible symptoms of Proprioception Dysfunction Syndrome (PDS).
The aim of this study was to investigate whether a patient with ME/CFS also had PDS, and to treat the patient following the non-invasive and inexpensive protocol for PDS from [13].
Methods.
A patient with severe ME/CFS was diagnosed with PDS using simple biomechanical tests that investigate body and visual-spatial perception.
The key elements of the treatment involve the use of glasses with ‘Active Prism’ lenses, combined with postural reprogramming.
We subsequently followed four further patients with the characterising symptoms of ME/CFS through diagnosis and treatment for PDS.
Results.
The results show a rapid recovery of the clinical state of the primary patient during the course of the treatment as measured on the Bell Fatigue Scale, allowing him to return quickly to professional life and to re-establish his pre-disease quality of life.
Of the four additional patients, one regained pre-disease levels of function, while the clinical state of the remaining three patients improved measurably.
Conclusions.
Research into the prevalence of PDS among ME/CFS patients should be carried out, and those ME/CFS patients with PDS should undertake the treatment that we describe (begining with postural reprogramming, see Appendix B).